FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093793136> ?p ?o ?g. }

• W2093793136 endingPage "604" @default.
• W2093793136 startingPage "596" @default.
• W2093793136 abstract "To determine the diagnostic accuracy of a semiautomated 18F-FDG PET/CT measurement of total lesion glycolysis (TLG), maximum and peak standardized uptake value at lean body mass (SUL-Max and SUL-Peak), qualitative estimates of left/right nodal symmetry and FDG uptake for differentiating lymphoma from reactive adenopathy in HIV-infected patients. We retrospectively analyzed 41 whole-body 18F-FDG PET/CT studies performed in HIV-infected patients for clinical reasons. The study received institutional review board approval. Of the 41 patients, 19 had biopsy-proven untreated lymphoma, and 22 with reactive adenopathy without malignancy on follow-up were used as controls. Nodal and extranodal visual qualitative metabolic scores, SUL-Max, SUL-Peak, CT nodal size, and PERCIST 1.0 threshold-based TLG and metabolic tumor volume (MTV) were determined. The qualitative intensity of nodal involvement and symmetry of uptake were compared using receiver operator curve (ROC) analysis. HIV plasma viral RNA measurements were also obtained. All of the quantitative PET metrics performed well in differentiating lymphoma from reactive adenopathy and performed better than qualitative visual intensity scores. The areas under the ROC curves (AUC) were significantly higher for TLG = 0.96, single SUL-Peak = 0.96, single SUL-Max = 0.97, and MTV = 0.96, compared to 0.67 for CT nodal size (p < 0.001). These PET metrics performed best in separating the two populations in aviremic patients, with AUCs of 1 (AUC 0.91 for CT nodal size). TLG, MTV, SUL-Peak and SUL-Max were more reliable markers among viremic individuals, with AUCs between 0.84 and 0.93, compared to other metrics. PET metrics were significantly correlated with plasma viral load in HIV-reactive adenopathy controls. Asymmetrical FDG uptake had an accuracy of 90.4 % for differentiating lymphoma from reactive adenopathy in HIV-infected patients. Quantitative PET metabolic metrics as well as the qualitative assessment of symmetry of nodal uptake appear to be valuable tools for differentiating lymphoma from reactive adenopathy in HIV-infected patients using FDG PET. These parameters appear more robust in aviremic patients." @default.
• W2093793136 created "2016-06-24" @default.
• W2093793136 creator A5011890756 @default.
• W2093793136 creator A5022454617 @default.
• W2093793136 creator A5036285787 @default.
• W2093793136 creator A5041082382 @default.
• W2093793136 creator A5055052806 @default.
• W2093793136 creator A5074418085 @default.
• W2093793136 creator A5080102032 @default.
• W2093793136 creator A5084422985 @default.
• W2093793136 date "2014-01-28" @default.
• W2093793136 modified "2023-10-14" @default.
• W2093793136 title "Differentiation of HIV-associated lymphoma from HIV-associated reactive adenopathy using quantitative FDG PET and symmetry" @default.
• W2093793136 cites W13885862 @default.
• W2093793136 cites W195145809 @default.
• W2093793136 cites W1982836986 @default.
• W2093793136 cites W1983590753 @default.
• W2093793136 cites W1984164382 @default.
• W2093793136 cites W1999078280 @default.
• W2093793136 cites W2005991279 @default.
• W2093793136 cites W2023469490 @default.
• W2093793136 cites W2035709588 @default.
• W2093793136 cites W2036315064 @default.
• W2093793136 cites W2040415254 @default.
• W2093793136 cites W2063884776 @default.
• W2093793136 cites W2065608903 @default.
• W2093793136 cites W2068055192 @default.
• W2093793136 cites W2089428206 @default.
• W2093793136 cites W2107929557 @default.
• W2093793136 cites W2115312840 @default.
• W2093793136 cites W2118954661 @default.
• W2093793136 cites W2142724147 @default.
• W2093793136 cites W2143130907 @default.
• W2093793136 cites W2148397464 @default.
• W2093793136 cites W2155263737 @default.
• W2093793136 cites W2156969810 @default.
• W2093793136 cites W2162086037 @default.
• W2093793136 cites W2164777277 @default.
• W2093793136 cites W2164841215 @default.
• W2093793136 doi "https://doi.org/10.1007/s00259-013-2671-9" @default.
• W2093793136 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4322908" @default.
• W2093793136 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24469258" @default.
• W2093793136 hasPublicationYear "2014" @default.
• W2093793136 type Work @default.
• W2093793136 sameAs 2093793136 @default.
• W2093793136 citedByCount "36" @default.
• W2093793136 countsByYear W20937931362014 @default.
• W2093793136 countsByYear W20937931362015 @default.
• W2093793136 countsByYear W20937931362016 @default.
• W2093793136 countsByYear W20937931362017 @default.
• W2093793136 countsByYear W20937931362018 @default.
• W2093793136 countsByYear W20937931362019 @default.
• W2093793136 countsByYear W20937931362020 @default.
• W2093793136 countsByYear W20937931362021 @default.
• W2093793136 countsByYear W20937931362022 @default.
• W2093793136 countsByYear W20937931362023 @default.
• W2093793136 crossrefType "journal-article" @default.
• W2093793136 hasAuthorship W2093793136A5011890756 @default.
• W2093793136 hasAuthorship W2093793136A5022454617 @default.
• W2093793136 hasAuthorship W2093793136A5036285787 @default.
• W2093793136 hasAuthorship W2093793136A5041082382 @default.
• W2093793136 hasAuthorship W2093793136A5055052806 @default.
• W2093793136 hasAuthorship W2093793136A5074418085 @default.
• W2093793136 hasAuthorship W2093793136A5080102032 @default.
• W2093793136 hasAuthorship W2093793136A5084422985 @default.
• W2093793136 hasBestOaLocation W20937931362 @default.
• W2093793136 hasConcept C126322002 @default.
• W2093793136 hasConcept C126838900 @default.
• W2093793136 hasConcept C199374082 @default.
• W2093793136 hasConcept C203014093 @default.
• W2093793136 hasConcept C2775842073 @default.
• W2093793136 hasConcept C2775934546 @default.
• W2093793136 hasConcept C2779338263 @default.
• W2093793136 hasConcept C2779399171 @default.
• W2093793136 hasConcept C2989005 @default.
• W2093793136 hasConcept C3013748606 @default.
• W2093793136 hasConcept C58471807 @default.
• W2093793136 hasConcept C71924100 @default.
• W2093793136 hasConcept C76318530 @default.
• W2093793136 hasConcept C83330619 @default.
• W2093793136 hasConceptScore W2093793136C126322002 @default.
• W2093793136 hasConceptScore W2093793136C126838900 @default.
• W2093793136 hasConceptScore W2093793136C199374082 @default.
• W2093793136 hasConceptScore W2093793136C203014093 @default.
• W2093793136 hasConceptScore W2093793136C2775842073 @default.
• W2093793136 hasConceptScore W2093793136C2775934546 @default.
• W2093793136 hasConceptScore W2093793136C2779338263 @default.
• W2093793136 hasConceptScore W2093793136C2779399171 @default.
• W2093793136 hasConceptScore W2093793136C2989005 @default.
• W2093793136 hasConceptScore W2093793136C3013748606 @default.
• W2093793136 hasConceptScore W2093793136C58471807 @default.
• W2093793136 hasConceptScore W2093793136C71924100 @default.
• W2093793136 hasConceptScore W2093793136C76318530 @default.
• W2093793136 hasConceptScore W2093793136C83330619 @default.
• W2093793136 hasIssue "4" @default.
• W2093793136 hasLocation W20937931361 @default.
• W2093793136 hasLocation W20937931362 @default.
• W2093793136 hasLocation W20937931363 @default.

• next